Annual SG&A
$11.65 M
+$4.21 M+56.64%
31 December 2023
Summary:
Armata Pharmaceuticals annual selling, general & administrative expenses is currently $11.65 million, with the most recent change of +$4.21 million (+56.64%) on 31 December 2023. During the last 3 years, it has risen by +$3.68 million (+46.23%). ARMP annual SG&A is now at all-time high.ARMP Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$3.24 M
-$195.00 K-5.67%
30 September 2024
Summary:
Armata Pharmaceuticals quarterly selling, general & administrative expenses is currently $3.24 million, with the most recent change of -$195.00 thousand (-5.67%) on 30 September 2024. Over the past year, it has dropped by -$339.00 thousand (-9.46%). ARMP quarterly SG&A is now -23.00% below its all-time high of $4.21 million, reached on 31 December 2000.ARMP Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.30 B
-$41.36 M-3.29%
30 September 2024
Summary:
Armata Pharmaceuticals TTM selling, general & administrative expenses is currently -$1.30 billion, with the most recent change of -$41.36 million (-3.29%) on 30 September 2024. Over the past year, it has dropped by -$1.31 billion (-12723.75%). ARMP TTM SG&A is now -13855.35% below its all-time high of $13.38 million, reached on 30 June 2024.ARMP TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARMP Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +56.6% | -9.5% | -10000.0% |
| 3 y3 years | +46.2% | +83.5% | -10000.0% |
| 5 y5 years | +104.3% | -13.7% | -10000.0% |
ARMP Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +56.6% | -9.5% | +107.8% | -72.3% | at low |
| 5 y | 5 years | at high | +104.3% | -13.7% | +107.8% | -109.7% | at low |
| alltime | all time | at high | +513.1% | -23.0% | +711.0% | <-9999.0% | +19.8% |
Armata Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.24 M(-5.7%) | $13.04 M(-2.5%) |
| June 2024 | - | $3.44 M(+8.2%) | $13.38 M(+8.9%) |
| Mar 2024 | - | $3.18 M(-0.0%) | $12.29 M(+5.5%) |
| Dec 2023 | $11.65 M(+56.6%) | $3.18 M(-11.3%) | $11.65 M(+13.3%) |
| Sept 2023 | - | $3.58 M(+52.5%) | $10.28 M(+24.5%) |
| June 2023 | - | $2.35 M(-7.4%) | $8.26 M(+3.3%) |
| Mar 2023 | - | $2.54 M(+40.2%) | $7.99 M(+7.5%) |
| Dec 2022 | $7.44 M(-10.2%) | $1.81 M(+16.0%) | $7.44 M(-5.3%) |
| Sept 2022 | - | $1.56 M(-25.1%) | $7.85 M(-2.6%) |
| June 2022 | - | $2.08 M(+5.0%) | $8.06 M(-0.7%) |
| Mar 2022 | - | $1.98 M(-10.8%) | $8.11 M(-2.0%) |
| Dec 2021 | $8.28 M(+4.0%) | $2.22 M(+25.7%) | $8.28 M(+3.1%) |
| Sept 2021 | - | $1.77 M(-17.3%) | $8.04 M(-0.9%) |
| June 2021 | - | $2.14 M(-0.6%) | $8.11 M(+2.1%) |
| Mar 2021 | - | $2.15 M(+8.8%) | $7.95 M(-0.3%) |
| Dec 2020 | $7.97 M(-14.0%) | $1.98 M(+7.2%) | $7.97 M(-0.8%) |
| Sept 2020 | - | $1.84 M(-6.5%) | $8.03 M(-19.2%) |
| June 2020 | - | $1.97 M(-9.1%) | $9.95 M(-1.1%) |
| Mar 2020 | - | $2.17 M(+6.2%) | $10.06 M(+8.5%) |
| Dec 2019 | $9.27 M(+62.5%) | $2.04 M(-45.6%) | $9.27 M(-17.4%) |
| Sept 2019 | - | $3.76 M(+80.5%) | $11.21 M(+40.7%) |
| June 2019 | - | $2.08 M(+50.9%) | $7.97 M(+10.0%) |
| Mar 2019 | - | $1.38 M(-65.4%) | $7.25 M(-2.8%) |
| Dec 2018 | $5.70 M(-24.9%) | $3.99 M(+676.8%) | $7.46 M(+56.7%) |
| Sept 2018 | - | $514.00 K(-62.2%) | $4.76 M(-18.8%) |
| June 2018 | - | $1.36 M(-14.5%) | $5.86 M(-19.6%) |
| Mar 2018 | - | $1.59 M(+22.9%) | $7.28 M(-4.0%) |
| Dec 2017 | $7.59 M(-9.8%) | $1.29 M(-19.7%) | $7.59 M(-3.1%) |
| Sept 2017 | - | $1.61 M(-42.1%) | $7.83 M(-2.1%) |
| June 2017 | - | $2.78 M(+46.7%) | $8.00 M(+4.3%) |
| Mar 2017 | - | $1.90 M(+23.5%) | $7.67 M(-8.9%) |
| Dec 2016 | $8.41 M(+25.4%) | $1.54 M(-13.7%) | $8.41 M(-3.6%) |
| Sept 2016 | - | $1.78 M(-27.3%) | $8.73 M(-0.7%) |
| June 2016 | - | $2.45 M(-7.3%) | $8.79 M(+10.5%) |
| Mar 2016 | - | $2.64 M(+42.7%) | $7.96 M(+18.6%) |
| Dec 2015 | $6.71 M(-2.0%) | $1.85 M(+0.5%) | $6.71 M(+4.5%) |
| Sept 2015 | - | $1.84 M(+14.0%) | $6.42 M(+2.3%) |
| June 2015 | - | $1.62 M(+15.7%) | $6.28 M(-5.2%) |
| Mar 2015 | - | $1.40 M(-10.5%) | $6.62 M(-3.4%) |
| Dec 2014 | $6.85 M(+14.2%) | $1.56 M(-8.2%) | $6.85 M(+5.2%) |
| Sept 2014 | - | $1.70 M(-13.3%) | $6.51 M(+8.1%) |
| June 2014 | - | $1.96 M(+20.5%) | $6.03 M(-12.8%) |
| Mar 2014 | - | $1.63 M(+32.9%) | $6.91 M(+15.2%) |
| Dec 2013 | $6.00 M(+86.9%) | $1.22 M(+0.7%) | $6.00 M(+25.6%) |
| Sept 2013 | - | $1.22 M(-57.3%) | $4.77 M(+34.2%) |
| June 2013 | - | $2.84 M(+298.2%) | $3.56 M(+398.2%) |
| Mar 2013 | - | $714.00 K(-47.2%) | $714.00 K(-84.8%) |
| Dec 2012 | $3.21 M(-44.9%) | - | - |
| Sept 2009 | - | $1.35 M(+30.5%) | $4.71 M(+2.8%) |
| June 2009 | - | $1.04 M(-23.9%) | $4.58 M(-13.5%) |
| Mar 2009 | - | $1.36 M(+42.2%) | $5.29 M(-9.1%) |
| Dec 2008 | $5.82 M(-17.2%) | $957.00 K(-21.8%) | $5.82 M(-17.7%) |
| Sept 2008 | - | $1.22 M(-30.1%) | $7.07 M(-6.2%) |
| June 2008 | - | $1.75 M(-7.3%) | $7.54 M(+2.4%) |
| Mar 2008 | - | $1.89 M(-14.4%) | $7.37 M(+4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2007 | $7.03 M(+10.1%) | $2.21 M(+30.3%) | $7.03 M(+8.7%) |
| Sept 2007 | - | $1.69 M(+7.6%) | $6.47 M(+0.1%) |
| June 2007 | - | $1.57 M(+1.5%) | $6.46 M(+0.1%) |
| Mar 2007 | - | $1.55 M(-5.7%) | $6.45 M(+1.1%) |
| Dec 2006 | $6.38 M(+1.1%) | $1.65 M(-2.4%) | $6.38 M(+6.1%) |
| Sept 2006 | - | $1.69 M(+7.6%) | $6.01 M(+3.4%) |
| June 2006 | - | $1.57 M(+5.9%) | $5.82 M(-1.6%) |
| Mar 2006 | - | $1.48 M(+15.9%) | $5.91 M(-6.4%) |
| Dec 2005 | $6.31 M(-5.1%) | $1.28 M(-14.2%) | $6.31 M(-1.3%) |
| Sept 2005 | - | $1.49 M(-10.2%) | $6.39 M(+0.2%) |
| June 2005 | - | $1.66 M(-11.9%) | $6.38 M(-6.0%) |
| Mar 2005 | - | $1.89 M(+38.8%) | $6.79 M(+2.0%) |
| Dec 2004 | $6.65 M(+21.1%) | $1.36 M(-8.0%) | $6.65 M(-3.3%) |
| Sept 2004 | - | $1.48 M(-28.6%) | $6.88 M(+5.3%) |
| June 2004 | - | $2.07 M(+18.1%) | $6.53 M(+10.6%) |
| Mar 2004 | - | $1.75 M(+10.5%) | $5.90 M(+7.5%) |
| Dec 2003 | $5.49 M(-31.9%) | $1.58 M(+39.7%) | $5.49 M(-27.0%) |
| Sept 2003 | - | $1.13 M(-21.2%) | $7.52 M(-1.2%) |
| June 2003 | - | $1.44 M(+7.6%) | $7.61 M(-1.8%) |
| Mar 2003 | - | $1.34 M(-63.0%) | $7.75 M(-12.0%) |
| Dec 2002 | $8.07 M(-5.4%) | $3.61 M(+195.7%) | $8.81 M(+0.2%) |
| Sept 2002 | - | $1.22 M(-22.6%) | $8.79 M(-2.7%) |
| June 2002 | - | $1.58 M(-34.1%) | $9.04 M(+1.5%) |
| Mar 2002 | - | $2.40 M(-33.4%) | $8.90 M(+4.3%) |
| Dec 2001 | $8.53 M(+13.3%) | $3.59 M(+144.8%) | $8.53 M(-6.8%) |
| Sept 2001 | - | $1.47 M(+1.8%) | $9.15 M(+4.0%) |
| June 2001 | - | $1.44 M(-28.9%) | $8.80 M(+4.1%) |
| Mar 2001 | - | $2.03 M(-51.9%) | $8.45 M(+12.2%) |
| Dec 2000 | $7.53 M(+109.2%) | $4.21 M(+276.4%) | $7.53 M(+66.7%) |
| Sept 2000 | - | $1.12 M(+2.5%) | $4.52 M(+2.7%) |
| June 2000 | - | $1.09 M(-1.4%) | $4.40 M(+9.8%) |
| Mar 2000 | - | $1.11 M(-7.8%) | $4.01 M(+8.3%) |
| Dec 1999 | $3.60 M(+20.0%) | $1.20 M(+20.0%) | $3.70 M(+8.8%) |
| Sept 1999 | - | $1.00 M(+42.9%) | $3.40 M(+9.7%) |
| June 1999 | - | $700.00 K(-12.5%) | $3.10 M(0.0%) |
| Mar 1999 | - | $800.00 K(-11.1%) | $3.10 M(0.0%) |
| Dec 1998 | $3.00 M(+7.1%) | $900.00 K(+28.6%) | $3.10 M(+6.9%) |
| Sept 1998 | - | $700.00 K(0.0%) | $2.90 M(0.0%) |
| June 1998 | - | $700.00 K(-12.5%) | $2.90 M(+3.6%) |
| Mar 1998 | - | $800.00 K(+14.3%) | $2.80 M(0.0%) |
| Dec 1997 | $2.80 M(-3.4%) | $700.00 K(0.0%) | $2.80 M(-6.7%) |
| Sept 1997 | - | $700.00 K(+16.7%) | $3.00 M(-3.2%) |
| June 1997 | - | $600.00 K(-25.0%) | $3.10 M(0.0%) |
| Mar 1997 | - | $800.00 K(-11.1%) | $3.10 M(+6.9%) |
| Dec 1996 | $2.90 M(+26.1%) | $900.00 K(+12.5%) | $2.90 M(+11.5%) |
| Sept 1996 | - | $800.00 K(+33.3%) | $2.60 M(+18.2%) |
| June 1996 | - | $600.00 K(0.0%) | $2.20 M(+4.8%) |
| Mar 1996 | - | $600.00 K(0.0%) | $2.10 M(-4.5%) |
| Dec 1995 | $2.30 M(+21.1%) | $600.00 K(+50.0%) | $2.20 M(+4.8%) |
| Sept 1995 | - | $400.00 K(-20.0%) | $2.10 M(-4.5%) |
| June 1995 | - | $500.00 K(-28.6%) | $2.20 M(0.0%) |
| Mar 1995 | - | $700.00 K(+40.0%) | $2.20 M(+46.7%) |
| Dec 1994 | $1.90 M(-65.5%) | $500.00 K(0.0%) | $1.50 M(+50.0%) |
| Sept 1994 | - | $500.00 K(0.0%) | $1.00 M(+100.0%) |
| June 1994 | - | $500.00 K | $500.00 K |
| Dec 1993 | $5.50 M | - | - |
FAQ
- What is Armata Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals annual SG&A year-on-year change?
- What is Armata Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals quarterly SG&A year-on-year change?
- What is Armata Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals TTM SG&A year-on-year change?
What is Armata Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of ARMP is $11.65 M
What is the all time high annual SG&A for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high annual selling, general & administrative expenses is $11.65 M
What is Armata Pharmaceuticals annual SG&A year-on-year change?
Over the past year, ARMP annual selling, general & administrative expenses has changed by +$4.21 M (+56.64%)
What is Armata Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of ARMP is $3.24 M
What is the all time high quarterly SG&A for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $4.21 M
What is Armata Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, ARMP quarterly selling, general & administrative expenses has changed by -$339.00 K (-9.46%)
What is Armata Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of ARMP is -$1.30 B
What is the all time high TTM SG&A for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high TTM selling, general & administrative expenses is $13.38 M
What is Armata Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, ARMP TTM selling, general & administrative expenses has changed by -$1.31 B (-12723.75%)